FAF2

Chr 5

Fas associated factor family member 2

Also known as: ETEA, UBXD8, UBXN3B

The FAF2 protein mediates endoplasmic reticulum-associated degradation of misfolded proteins, regulates insulin-like growth factor receptor signaling, inhibits lipid droplet degradation, and promotes stress granule disassembly. Mutations cause autosomal recessive neurodevelopmental disorder with progressive microcephaly, seizures, and brain atrophy. This gene is highly constrained against loss-of-function variants, indicating that such mutations are typically pathogenic.

ResearchSummary from RefSeq, UniProt
LOEUF 0.22
Clinical SummaryFAF2
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.22LOEUF
pLI 0.999
Z-score 4.66
OE 0.07 (0.030.22)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.52Z-score
OE missense 0.56 (0.490.64)
144 obs / 258.0 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.07 (0.030.22)
00.351.4
Missense OE0.56 (0.490.64)
00.61.4
Synonymous OE0.95
01.21.6
LoF obs/exp: 2 / 29.2Missense obs/exp: 144 / 258.0Syn Z: 0.39

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FAF2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →